As the co-founder and chief executive officer of Medable, Dr Michelle Longmire is mission-driven to accelerate the development of new therapies for disease.
While we may only be two months into 2023, amid growing pressure to justify high drug prices, address trial backlogs, manage staffing shortages, while continuing to develop lifesaving treatments fo
As the healthcare industry emerges from the COVID-19 pandemic into a new, digitally supercharged world, stakeholders across the industry are moving fast to embrace digital transformation.
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough
